Belo Andreza Alves, Sousa Marinez de Oliveira, Machado Eduardo Luis Guimarães, Figueiredo Amintas Fabiano de Souza
Department of Análises Clinicas e Toxicológicas, Faculdade de Farmacia, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, MG, Brazil.
Ethn Dis. 2009 Summer;19(3):265-70.
To evaluate the possible relationship between the human tissue kallikrein amidase activity with sex and ethnicity in Brazilian primary hypertensive patients.
Population-based study.
One hundred men and women, Black and White primary hypertensive patients aged 20 years and older were selected. Eighty nine healthy individuals, paired according to age, sex, and ethnics were used as controls.
Early-morning midstream urine was used. Human tissue kallikrein amidase activity was estimated with D-Val-Leu-Arg 4-nitroanilide substrate. Creatinine was determined by a method based on Jaffe's reaction. hK1 amidase activity is expressed in microM/(min x mg creatinine) to correct for differences in urine flow rate. Data are expressed as medians.
Human tissue kallikrein amidase activity was significantly lower in the urine of hypertensive patients (0.210 microM/(min x mg creatinine) than in the urine of control subjects (0.260 microM/(min x mg creatinine) (P = .010). This result supports data from the literature. Contrasting to what was already reported, namely that human tissue kallikrein excretion is higher in females than in males, and especially higher in Caucasians than in African Americans, our results show that, in the urine of Brazilian hypertensive patients and control subjects, no significant effect of sex and ethnicity on human tissue kallikrein amidase activity was observed.
The lack of ethnicity effect supports what was already asserted, namely, that, in Brazil, at an individual level, color, as determined by physical evaluation, is a poor predictor of genomic African ancestry, estimated by molecular markers.
评估巴西原发性高血压患者中人类组织激肽释放酶酰胺酶活性与性别和种族之间的可能关系。
基于人群的研究。
选取了100名年龄在20岁及以上的黑人和白人原发性高血压男性和女性患者。89名根据年龄、性别和种族配对的健康个体作为对照。
使用清晨中段尿。用D-缬氨酸-亮氨酸-精氨酸4-硝基苯胺底物估计人类组织激肽释放酶酰胺酶活性。肌酐通过基于杰氏反应的方法测定。hK1酰胺酶活性以微摩尔/(分钟×毫克肌酐)表示,以校正尿流率差异。数据以中位数表示。
高血压患者尿液中的人类组织激肽释放酶酰胺酶活性(0.210微摩尔/(分钟×毫克肌酐))显著低于对照受试者尿液中的活性(0.260微摩尔/(分钟×毫克肌酐))(P = 0.010)。这一结果支持了文献数据。与已报道的情况相反,即人类组织激肽释放酶排泄在女性中高于男性,尤其是在白种人中高于非裔美国人,我们的结果表明,在巴西高血压患者和对照受试者的尿液中,未观察到性别和种族对人类组织激肽释放酶酰胺酶活性有显著影响。
种族效应的缺乏支持了已有的论断,即在巴西,在个体层面,通过体格评估确定的肤色并不能很好地预测通过分子标记估计的非洲基因组血统。